INS and Alzheimer disease: Development of the intranasal insulin treatment [22] has led to multiple human clinical trials demonstrating increased brain cell energy in healthy adults [23] and improved memory in healthy adults [24] and individuals with mild cognitive impairment or AD [25,26].